Skip to Main Content

Paper Details

A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Target Oncol
6
2022
Author NameAffiliation
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network, University of Toronto, University Avenue
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto, University Avenue
  • 1 - 2

Datasets

Release 1.2